Legend Biotech Corp — Investor Relations & Filings
Legend Biotech Corp. is a global, commercial-stage biotechnology company that discovers, develops, manufactures, and commercializes novel cell therapies. The company's primary focus is on treating life-threatening diseases, with a significant emphasis on oncology. Its lead product is CARVYKTI® (ciltacabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of relapsed or refractory multiple myeloma. This therapy is developed and commercialized in collaboration with Johnson & Johnson. Legend Biotech is building an end-to-end cell therapy platform to maximize patient access to its treatments and to advance its pipeline of cutting-edge cell therapy modalities for various diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2026-05-21 | English | |
| 6-K - Legend Biotech Corp (0001801198) (Filer) | 2026-05-12 | English | |
| 6-K - Legend Biotech Corp (0001801198) (Filer) | 2026-04-14 | English | |
| 4 - Legend Biotech Corp (0001801198) (Issuer) | 2026-03-27 | English | |
| 144 - Legend Biotech Corp (0001801198) (Subject) | 2026-03-26 | English | |
| 3 - Legend Biotech Corp (0001801198) (Issuer) | 2026-03-19 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Legend Biotech Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30908/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30908 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30908 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30908 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30908}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Legend Biotech Corp (id: 30908)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.